Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bruce Dezube"'
Autor:
Mazyar Shadman, Cecilia Yeung, Mary W Redman, Sang Yun Lee, Dong Hoon Lee, Susan Ra, David H Qian, Bruce Dezube, Aude Chapuis, Damian Green, Andrew Cowan, Ryan Cassaday, Hans-Peter Kiem, Houston E Warren, Filippo Milano, Jordan Gauthier, Alexandre Hirayama, Mary Kwok, Chaitra Ujjani, David Maloney, Ajay Gopal, Brian Till
Publikováno v:
HemaSphere, Vol 7, p e68877ca (2023)
Externí odkaz:
https://doaj.org/article/d8bb754945964d2fac1aef76598bd45e
Autor:
Yan Wang, John Powderly, Marc Ernstoff, Anthony Shields, Ulka Vaishampayan, John Wrangle, Sarina Piha-Paul, Anthony Olszanski, Lei Sun, Bradley Carthon, Kelly Curtis, Ilda Bidollari, Yangchun Du, Emily Putiri, Heather Losey, Bruce Dezube
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/1ad3ff19fadb4798b39071e0dee24631
Autor:
Christine E. Brown, Agata Xella, Jonathan C. Hibbard, Vanessa Salvary, Brenda Aguilar, Jamie Wagner, Bruce Dezube, Knut Niss, Lynn Bayless, James Edinger, Jianmei Leavenworth, Stephen J. Forman, Behnam Badie, James M. Markert, Kevin A. Cassady
Publikováno v:
Cancer Research. 82:CT541A-CT541A
The combination of chimeric antigen receptor (CAR) T cell therapy, which delivers large numbers of tumor reactive T cells, and oncolytic viral therapy, causing activation of host immune responses, is an attractive approach for improving outcomes for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5634b0b04c9e714bf0919ce4bc70f85d
https://doi.org/10.1158/1538-7445.am2022-ct541a
https://doi.org/10.1158/1538-7445.am2022-ct541a
Autor:
John Powderly, Bradley Carthon, Marc Ernstoff, Anthony Olszanski, John Wrangle, Anthony Shields, Sarina Piha-Paul, Kelly Curtis, Ilda Bidollari, Yangchun Du, Lei Sun, Emily Putiri, Yan Wang, Heather Losey, Bruce Dezube, Ulka Vaishampayan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background ALKS 4230 is a novel engineered cytokine designed to selectively bind and activate the intermediate affinity IL-2 receptor. Intravenous (IV) dosing of ALKS 4230 has shown encouraging efficacy and acceptable tolerability, as monotherapy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be59d8e703ebaa05caaf1585a113fc8e
https://doaj.org/article/1ad3ff19fadb4798b39071e0dee24631
https://doaj.org/article/1ad3ff19fadb4798b39071e0dee24631
Autor:
Christopher J. Hoimes, Ulka N. Vaishampayan, Olivier Dumas, Valentina Boni, Marc S. Ernstoff, Yangchun Du, Anna Spreafico, Aman Chauhan, Arvind Chaudhry, Vamsidhar Velcheti, Ira Winer, Lucy Gilbert, Heather C. Losey, Ilda Bidollari, Jessicca Martin Rege, Jameel Muzaffar, Bruce Dezube, Quincy Chu, Piotr Tomczak, Seth David Rosen, Kelly Curtis, David F. McDermott, Elizabeth Dorn, Lei Sun, Yan Wang, James Strauss, Debora S. Bruno, Emily Putiri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background ALKS 4230 is a novel engineered cytokine that selectively targets the intermediate-affinity interleukin-2 receptor complex to activate CD8+ T cells and natural killer cells.1 The ARTISTRY-1 trial (NCT02799095) has shown encouraging efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92d9321692e6159eed965d5d8bb793c
https://doaj.org/article/5558dc32bb3f46a4a9c1044cc2c6eec4
https://doaj.org/article/5558dc32bb3f46a4a9c1044cc2c6eec4
Autor:
Yangchun Du, Ulka N. Vaishampayan, David F. McDermott, Q.S-C. Chu, Olivier Dumas, Emily Putiri, Ilda Bidollari, H.C. Losey, Lei Sun, H. Hirte, Marc S. Ernstoff, Ira Winer, Lucy Gilbert, K.K. Curtis, Christopher J. Hoimes, Bruce Dezube, S.D. Rosen, J. Muzaffar, Vamsidhar Velcheti, Anna Spreafico
Publikováno v:
Annals of Oncology. 31:S708-S709
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3110b741986f4d54762f545b324c11ae
https://doi.org/10.1016/j.annonc.2020.08.1147
https://doi.org/10.1016/j.annonc.2020.08.1147
Autor:
T W Cheung, Scot C. Remick, J Bruce Dezube, J H Von Roenn, Parkash S. Gill, J Holdon-Wiltse, J-P Sommadossi, S L Shriver, Timothy P. Cooley, C W Suckow
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14:A35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c45ea3db1fa16666ccdc0789ee422548
https://doi.org/10.1097/00042560-199704010-00119
https://doi.org/10.1097/00042560-199704010-00119
Publikováno v:
American Journal of Clinical Pathology; Oct2007, Vol. 128 Issue 4, p596-603, 8p
Publikováno v:
Journal of the Chemical Society, Perkin Transactions 2. :730
The conformation of the amino-acid tryptophan in solution has been examined by n.m.r. methods. Coupling constants, nuclear Overhauser effects, and lanthanide perturbations were all analysed in terms of six conformers, each having one of three values
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::805a5361f1d881b8dd07056ca8fbf6db
https://doi.org/10.1039/p29810000730
https://doi.org/10.1039/p29810000730
Autor:
Bruce Dezube
Publikováno v:
Journal of Chemical Education. 56:313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b05ae86e01b7925c2a929dd1fba5986
https://doi.org/10.1021/ed056p313
https://doi.org/10.1021/ed056p313